Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
16.96
+2.33 (15.93%)
At close: Nov 4, 2024, 4:00 PM
16.90
-0.06 (-0.35%)
After-hours: Nov 4, 2024, 5:53 PM EST

Monopar Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Market Capitalization
875314070173
Upgrade
Market Cap Growth
12.92%-83.48%-24.23%-42.33%-59.48%-
Upgrade
Enterprise Value
68-3161852169
Upgrade
Last Close Price
14.631.7011.8516.0530.6083.00
Upgrade
PE Ratio
--0.56-2.87-4.40-10.64-36.62
Upgrade
PB Ratio
8.460.913.032.134.4713.70
Upgrade
P/FCF Ratio
-1.87-0.64-4.24-5.52-15.03-57.32
Upgrade
P/OCF Ratio
-1.87-0.64-4.24-5.52-15.03-57.32
Upgrade
EV/EBIT Ratio
-0.530.39-1.55-1.98-8.02-38.97
Upgrade
EV/FCF Ratio
-0.580.44-2.26-2.47-11.20-55.84
Upgrade
Debt / Equity Ratio
--0.00---
Upgrade
Debt / FCF Ratio
--0.00---
Upgrade
Quick Ratio
6.534.134.1912.8514.2218.25
Upgrade
Current Ratio
6.594.174.2112.9814.2818.27
Upgrade
Return on Equity (ROE)
-102.31%-107.19%-72.44%-52.57%-44.52%-43.23%
Upgrade
Return on Assets (ROA)
-53.44%-53.66%-39.03%-30.51%-26.92%-26.15%
Upgrade
Return on Capital (ROIC)
-67.23%-70.38%-45.36%-32.94%-28.73%-27.65%
Upgrade
Earnings Yield
-9.47%-166.13%-34.34%-22.52%-9.00%-2.44%
Upgrade
FCF Yield
-9.06%-155.38%-23.61%-18.11%-6.65%-1.74%
Upgrade
Buyback Yield / Dilution
-19.36%-8.69%-1.97%-13.82%-17.56%-0.32%
Upgrade
Total Shareholder Return
-19.36%-8.69%-1.97%-13.82%-17.56%-0.32%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.